Article ID Journal Published Year Pages File Type
8459276 Radiotherapy and Oncology 2018 7 Pages PDF
Abstract
Reducing doses to all salivary glands maximizes PROMs. A cSMG dose constraint of ≤39 Gy does not increase failure risk.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , , , , , ,